BNTC Operating Income Growth
Benitec Biopharma Inc · Operating Income Growth
BNTC Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.57%period ending
BNTC TTM Operating Income YoY % (-120.04% → -22.57%)
Year-over-year change
High-resolution chart · PNG
BNTC operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -22.5715% | |
| -24.3256% | |
| -83.9414% | |
| -104.2978% | |
| -85.7048% | |
| -74.3858% | |
| -21.1737% | |
| -9.973% | |
| -17.8659% | |
| -11.5367% | |
| -17.9682% | |
| -15.6816% | |
| -6.8664% | |
| -13.5341% | |
| -6.2583% | |
| -11.9779% | |
| -31.3157% | |
| -34.3891% | |
| -40.5514% | |
| -30.5263% | |
| -22.5841% | |
| -21.8462% | |
| -31.9866% | |
| -380.0104% | |
| -431.7301% | |
| -404.4541% | |
| -347.1235% | |
| 17.624% | |
| 133.5745% | |
| 131.8305% | |
| 133.4036% | |
| 72.7832% | |
| 17.0255% | |
| 14.9797% | |
| 14.4274% | |
| 32.4534% | |
| 44.2287% | |
| 40.8874% | |
| 36.5274% | |
| 3.1951% | |
| -90.3719% | |
| -114.7231% | |
| -134.7946% | |
| -109.0556% | |
| -53.1798% | |
| -57.7591% | |
| -70.6555% | |
| -91.7703% | |
| -120.0393% |